{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:18:44Z","timestamp":1762186724203,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007526","name":"Universit\u00e9 Fran\u00e7ois-Rabelais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007526","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ijpara.2017.12.006","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T02:22:46Z","timestamp":1520475766000},"page":"561-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis"],"prefix":"10.1016","volume":"48","author":[{"given":"Esp\u00e9rance","family":"Moine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Moir\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Dimier-Poisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e9vin","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Couet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Colas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Van Langendonck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Enguehard-Gueiffier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Gueiffier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"H\u00e9raut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Denevault-Sabourin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Debierre-Grockiego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpara.2017.12.006_b0005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/AAC.38.3.570","article-title":"Rifabutin is active in murine models of toxoplasmosis","volume":"38","author":"Araujo","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpara.2017.12.006_b0010","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.4315\/0362-028X.JFP-11-418","article-title":"Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation","volume":"75","author":"Batz","year":"2012","journal-title":"J. Food Prot."},{"key":"10.1016\/j.ijpara.2017.12.006_b0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bjid.2013.10.003","article-title":"Trends in overall opportunistic illnesses, Pneumocystis carinii pneumonia, cerebral toxoplasmosis and Mycobacterium avium complex incidence rates over the 30\u202fyears of the HIV epidemic: a systematic review","volume":"18","author":"Coelho","year":"2014","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.ijpara.2017.12.006_b0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/1087057103255988","article-title":"Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates","volume":"8","author":"Di","year":"2003","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ijpara.2017.12.006_b0025","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1128\/AAC.01823-13","article-title":"Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection","volume":"58","author":"Doggett","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpara.2017.12.006_b0030","first-page":"4634","article-title":"The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2015","volume":"14","author":"EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control)","year":"2016","journal-title":"EFSA J."},{"key":"10.1016\/j.ijpara.2017.12.006_b0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jps.2600760902","article-title":"Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design","volume":"76","author":"Hansch","year":"1987","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpara.2017.12.006_b0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrm1679","article-title":"Plants, symbiosis and parasites: a calcium signalling connection","volume":"6","author":"Harper","year":"2005","journal-title":"Nat. Rev. Molec. Cell Biol."},{"key":"10.1016\/j.ijpara.2017.12.006_b0050","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ajo.2003.09.040","article-title":"Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease","volume":"136","author":"Holland","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpara.2017.12.006_b0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tips.2015.04.011","article-title":"Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans","volume":"36","author":"Hui","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijpara.2017.12.006_b0060","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1021\/jm201713h","article-title":"Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-Toxoplasma activity","volume":"55","author":"Johnson","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpara.2017.12.006_b0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijoa.2010.03.002","article-title":"Side effects of spiramycin masquerading as local anesthetic toxicity during labor epidural analgesia","volume":"19","author":"Julliac","year":"2010","journal-title":"Int. J. Obstet. Anesth."},{"key":"10.1016\/j.ijpara.2017.12.006_b0070","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1074\/jbc.M011045200","article-title":"Toxoplasma gondii attachment to host cells is regulated by a calmodulin-like domain protein kinase","volume":"276","author":"Kieschnick","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpara.2017.12.006_b0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1469-0691.2001.00224.x","article-title":"Quantitative detection of Toxoplasma gondii DNA in human body fluids by TaqMan polymerase chain reaction","volume":"7","author":"Kupferschmidt","year":"2001","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijpara.2017.12.006_b0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nature09022","article-title":"Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma","volume":"465","author":"Lourido","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijpara.2017.12.006_b0085","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1021\/jm4001314","article-title":"Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by Toxoplasma gondii","volume":"56","author":"Lourido","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpara.2017.12.006_b0090","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/AAC.01203-07","article-title":"In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone","volume":"52","author":"Meneceur","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpara.2017.12.006_b0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejmech.2015.10.004","article-title":"Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii Calcium-Dependent Protein Kinase 1","volume":"105","author":"Moine","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpara.2017.12.006_b0100","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3923\/jbs.2008.1110.1114","article-title":"Optimization of rat liver microsomal stability assay using HPLC","volume":"8","author":"Mondal","year":"2008","journal-title":"J. Biol. Sci."},{"key":"10.1016\/j.ijpara.2017.12.006_b0105","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1086\/590149","article-title":"Management of Toxoplasma gondii infection during pregnancy","volume":"47","author":"Montoya","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ijpara.2017.12.006_b0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fmicb.2017.00025","article-title":"A Systematic Review of In vitro and in vivo activities of anti-Toxoplasma drugs and compounds (2006\u20132016)","volume":"8","author":"Montazeri","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpara.2017.12.006_b0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkm476","article-title":"Tissue concentrations: do we ever learn?","volume":"61","author":"Mouton","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpara.2017.12.006_b0120","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkx134","article-title":"Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis","author":"M\u00fcller","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpara.2017.12.006_b0125","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nsmb.1818","article-title":"Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors","volume":"17","author":"Ojo","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijpara.2017.12.006_b0130","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.7b01192","article-title":"Inhibition of calcium dependent protein kinase 1 (CDPK1) by pyrazolopyrimidine analogs decreases establishment and reoccurrence of central nervous system disease by Toxoplasma gondii","author":"Rutaganira","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpara.2017.12.006_b0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1051\/parasite\/1998054359","article-title":"Phenylalanine derivatives active against Toxoplasma gondii brain cysts in mice","volume":"5","author":"Sarciron","year":"1998","journal-title":"Parasite"},{"key":"10.1016\/j.ijpara.2017.12.006_b0140","first-page":"195727","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharm."},{"key":"10.1016\/j.ijpara.2017.12.006_b0145","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1017\/S0950268814003185","article-title":"An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years","volume":"143","author":"Scallan","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.ijpara.2017.12.006_b0150","first-page":"1716","article-title":"Use of the kinase inhibitor analog 1-NM-PP1 reveals a role for Toxoplasma gondii CDPK1 in the invasion step","volume":"15","author":"Sugi","year":"2010","journal-title":"Eukaryotic Cell"},{"key":"10.1016\/j.ijpara.2017.12.006_b0155","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2471\/BLT.12.111732","article-title":"The global burden of congenital toxoplasmosis: a systematic review","volume":"91","author":"Torgerson","year":"2013","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ijpara.2017.12.006_b0160","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1021\/acs.jmedchem.6b00760","article-title":"Development of an orally available and central nervous system (CNS) penetrant Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitor with minimal human ether-a-go-go-related gene (hERG) activity for the treatment of toxoplasmosis","volume":"59","author":"Vidadala","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpara.2017.12.006_b0165","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1128\/AAC.01236-15","article-title":"In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum","volume":"59","author":"Winzer","year":"2015","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["International Journal for Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020751918300511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020751918300511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:49:09Z","timestamp":1762184949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020751918300511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0020751918300511"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpara.2017.12.006","relation":{},"ISSN":["0020-7519"],"issn-type":[{"type":"print","value":"0020-7519"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpara.2017.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}